Lantheus' oncology portfolio includes Pylarify (piflufolastat F 18) and a growing pipeline addressing various solid tumours.

Research indicates longer REM latency is associated with higher Alzheimer's biomarkers, pointing to its potential as an early indicator of neurodegeneration.

Amyloid-PET (using 18 F-florbetapir) demonstrated moderate widespread amyloid deposition; CSF analysis showed reduced amyloid-beta 1–42 and high-normal total tau. Formal neuropsychological testing ...

The Global Radiopharmaceuticals Market is expected to reach USD 7,225.6 Million by 2024 with further increases expected up until 2033, at an anticipated compound annual growth rate of 3.5% ...

Alzheimer's is a progressive mental deterioration in which brain cells deteriorate to an extent that leads to severe memory loss and cognitive function. Can dementia risk be reduced from childhood ...

Partnerships in Pharma--An Economist Intelligence Unit Seminar--Building Innovation into Alliances and Business Models. 1 October 2010, London, UK.

Despite the acceleration of knowledge and data accumulation in neuroscience over the last years, the highly prevalent neurodegenerative disease of AD remains a growing problem. Alzheimer's Disease (AD ...

Introduction: While the prevalence of neurodegenerative diseases associated with dementia such as Alzheimer's disease (AD) increases, our knowledge on the underlying mechanisms, outcome predictors, or ...

2 Department of Radiology, VU University Medical Centre, Amsterdam, Netherlands 3 Department of Neurology, VU University Medical Centre, Amsterdam, Netherlands Correspondence to Professor Nick C Fox, ...